Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing
We observed a high level of agreement with genetic counselor assessments, affirming the tool's clinical validity in identifying individuals for hereditary cancer predisposition testing and its potential for increasing access to hereditary cancer risk assessment.
Authors
- Ashley Daley
- Kiley J. Johnson
- Colleen Caleshu (ORCID: https://orcid.org/0000-0002-5339-8150)
- Kaylene Ready
- Mark E. Sylvester
- Cary M. Armstrong
- Hanah S. Cytron
- Durand R. Van Arnem
- Callan D. Russell
- Jill N. Davies
- Andi Hila
Institutions
- Northside Hospital (US)
- Second Genome (United States) (US)
Publication Details
- Journal
- Hereditary Cancer in Clinical Practice
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s13053-024-00298-0
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.55